You get your lab results back, and there is a block of cholesterol numbers, some of them flagged in yellow or red, and no one has actually sat down and told you what any of it means. That is the most common way people meet their lipid panel: a little alarmed, a little confused, and not sure whether they are supposed to change their diet, start a pill, or ignore the whole thing until next year.
This post walks through what each number on a standard cholesterol panel measures, what the newer markers add, and, most importantly, why no single number decides anything on its own. The goal is not to turn you into your own clinician. It is to help you read your own report and ask sharper questions the next time you sit across from one of us.
The four numbers on a standard panel
A basic lipid panel reports four things, usually in milligrams per deciliter (mg/dL) (https://medlineplus.gov/cholesterollevelswhatyouneedtoknow.html).
Total cholesterol is exactly what it sounds like -- the sum of the cholesterol carried in all your particles. It is the least useful number by itself, because a high total can come from high "bad" cholesterol or high "good" cholesterol, and those mean opposite things.
LDL cholesterol, the low-density lipoprotein, is the one most people have heard about. LDL particles carry cholesterol into the walls of your arteries, where it can build up over decades. Higher LDL generally means higher risk, and lowering it is the main target of cholesterol treatment.
HDL cholesterol, the high-density lipoprotein, works in roughly the opposite direction. HDL helps carry cholesterol away from the artery wall and back to the liver. Higher is generally better here, and a very low HDL is one of the things that pushes risk up.
Triglycerides are a separate kind of fat that your body uses for energy and stores when there is a surplus. A normal fasting triglyceride level is below 150 mg/dL, with 150 to 199 counted as borderline and 200 or above counted as high (https://medlineplus.gov/cholesterollevelswhatyouneedtoknow.html). High triglycerides often travel with excess weight, high blood sugar, and alcohol intake.
Non-HDL: the number worth finding
Look for one more value that many panels calculate for you: non-HDL cholesterol. It is simply your total cholesterol minus your HDL. What is left is all the cholesterol carried by the particles that can actually clog an artery -- LDL plus a few related types.
Non-HDL is useful because it captures more of the harmful particles than LDL alone, and it stays reliable even when you have not fasted or when your triglycerides are high. If your report shows it, it is often a better summary of your risk than the LDL number sitting right above it.
Why one number never tells the story
Here is the part that surprises people most: a single flagged value, on its own, rarely settles anything.
Cholesterol matters because of what it does to your arteries over years, and that damage depends on far more than one lab result. National guidelines assess your whole risk picture -- your age, whether you have diabetes, your blood pressure, whether you smoke, your family history, and an estimated 10-year risk of a heart attack or stroke -- rather than reacting to any one number in isolation (https://pubmed.ncbi.nlm.nih.gov/30423393/).
That is why two people with the identical LDL can get completely different advice. A 35-year-old with no other risk factors and an LDL of 145 is in a very different situation from a 62-year-old smoker with high blood pressure and the same LDL. The number is the same. The meaning is not.
The newer markers: ApoB and Lp(a)
Two blood tests that used to live only in specialist offices are now worth understanding, because they explain risk that a standard panel can miss.
ApoB, or apolipoprotein B, is a protein found on every harmful, artery-clogging particle -- one ApoB per particle. Measuring it is essentially counting those particles directly, rather than estimating the cholesterol inside them. That distinction matters because two people can have the same LDL cholesterol while carrying very different numbers of particles, and it is the particle count that tracks damage. A growing body of evidence suggests ApoB reflects cardiovascular risk more accurately than LDL or non-HDL, especially in people with diabetes, obesity, or high triglycerides (https://pubmed.ncbi.nlm.nih.gov/31642874/).
Lp(a), pronounced "L-P-little-a," is a different animal. It is a cholesterol particle you are largely born with -- your level is set mostly by your genes and changes little over your life. A high Lp(a) raises the risk of heart attack, stroke, and narrowing of the aortic valve on its own, independent of your other numbers, and it is common enough that a scientific statement from the American Heart Association describes it as a prevalent, causal risk factor worth measuring (https://pubmed.ncbi.nlm.nih.gov/34647487/). Because it stays stable, most people only need it checked once. It is especially worth asking about if heart disease showed up early in your family.
Lifestyle, medication, and the honest tradeoff
When the numbers and the overall risk suggest something should change, the question becomes how.
Lifestyle is the foundation, and it is not a consolation prize. Reducing saturated fat, moving more, losing excess weight, and quitting smoking all shift the panel in the right direction and improve risk through channels that no pill fully replaces (https://www.cdc.gov/cholesterol/about/index.html). For people at low to moderate risk with only mildly elevated numbers, lifestyle changes are often the entire plan, and we give them a real trial before adding anything.
Statins enter the conversation when your risk is high enough that the benefit clearly outweighs the downsides. The evidence here is unusually strong: across large trials, lowering LDL by about 39 mg/dL with a statin reduces major cardiovascular events by roughly one-fifth, and that proportional benefit holds across a wide range of people (https://www.thelancet.com/article/S0140-6736(10)61350-5/fulltext). For primary prevention, the US Preventive Services Task Force recommends a statin for adults aged 40 to 75 who have at least one risk factor and an estimated 10-year risk of 10 percent or higher (https://jamanetwork.com/journals/jama/fullarticle/2795521).
We will also name the tradeoffs plainly. Statins carry a small risk of muscle aches and a modest effect on blood sugar for some people, and those are real considerations we weigh with you rather than wave away. The right answer depends on your starting risk, your preferences, and how your body responds, which is a conversation, not a formula.
What to do with your own report
If you are holding a cholesterol panel right now, three habits will serve you well. First, look at non-HDL, not just LDL, if your report lists it. Second, resist the urge to read any one flagged number as a verdict -- your age, blood pressure, diabetes status, and family history change what it means. Third, if heart disease runs in your family or your standard numbers sit in a gray zone, ask whether ApoB or Lp(a) would add anything for you.
At NoMi Beach Health, Dr. Jezwah Harris reads a lipid panel the way it is meant to be read: as one input into your full cardiovascular picture, not a scorecard. That means we look at the numbers alongside your history, your other labs, and your goals, and we explain the reasoning instead of just circling a value in red. You can read more about how we approach preventive care on our primary care page, and you will find related plain-language explainers on our blog.
If your cholesterol has you uncertain, or you simply want someone to walk you through your results without rushing, book a visit through our primary care services or call us at (786) 744-5152. We will look at the whole panel, the whole person, and tell you what the evidence actually supports for you.
Frequently Asked Questions
- What is a lipid panel actually measuring?
- A standard lipid panel reports total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides, and it usually calculates non-HDL cholesterol from those. These are different fats and fat-carrying particles in your blood, and each one tells a slightly different part of the story about your risk for heart disease and stroke.
- Do I need to fast before a cholesterol test?
- Often no. Non-fasting panels are accepted for most routine screening, and the LDL and non-HDL values hold up well without fasting. Your clinician may still ask you to fast if your triglycerides are very high or if they are tracking a specific number over time.
- Is a single high LDL number enough to put me on a statin?
- Usually not by itself. Guidelines assess your whole picture -- age, blood pressure, diabetes, smoking, family history, and an estimated 10-year risk score -- rather than one value in isolation (https://pubmed.ncbi.nlm.nih.gov/30423393/). The number matters, but the context around it matters just as much.
- What are ApoB and Lp(a), and should I ask for them?
- ApoB counts the actual number of cholesterol-carrying particles that drive artery disease and can track risk more precisely than LDL alone (https://pubmed.ncbi.nlm.nih.gov/31642874/). Lp(a) is a mostly inherited particle that raises risk independently and is typically checked once in a lifetime (https://pubmed.ncbi.nlm.nih.gov/34647487/). They are worth discussing if you have early family heart disease or borderline standard numbers.
- How much does a statin actually lower risk?
- Across large trials, lowering LDL by about 39 mg/dL with a statin reduces major cardiovascular events by roughly one-fifth (https://www.thelancet.com/article/S0140-6736(10)61350-5/fulltext). The size of the benefit for you depends on your starting risk, which is why we personalize the decision.
- Can I fix my cholesterol with lifestyle alone?
- Sometimes, especially when your risk is low to moderate and your numbers are only mildly off. Diet, activity, weight, and quitting smoking all move the panel. When risk is higher or the numbers are far from goal, lifestyle and medication together usually give the best protection, and we decide that with you rather than for you.
Sources
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC Multisociety Guideline on the Management of Blood Cholesterol. Circulation (2019).
- US Preventive Services Task Force. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Recommendation Statement. JAMA (2022).
- Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiology (2019).
- Reyes-Soffer G, Ginsberg HN, Berglund L, et al. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for ASCVD. Arteriosclerosis, Thrombosis, and Vascular Biology (2022).
- Cholesterol Treatment Trialists' Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of 26 randomised trials. Lancet (2010).
- Chou R, Cantor A, Dana T, et al. Statin Use for the Primary Prevention of CVD in Adults: Updated Evidence Report for the USPSTF. JAMA (2022).
- MedlinePlus. Cholesterol Levels: What You Need to Know. National Library of Medicine.
- Centers for Disease Control and Prevention. About Cholesterol.



